Inhibition of type I allergic responses with nanogram doses of replicon-based DNA vaccines.
about
Allergens are not pathogens: why immunization against allergy differs from vaccination against infectious diseasesA mimotope gene encoding the major IgE epitope of allergen Phl p 5 for epitope-specific immunizationThe influence of antigen targeting to sub-cellular compartments on the anti-allergic potential of a DNA vaccine.mRNA vaccination as a safe approach for specific protection from type I allergy.A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugsWhat is the antiallergic potential of DNA vaccination?
P2860
Inhibition of type I allergic responses with nanogram doses of replicon-based DNA vaccines.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Inhibition of type I allergic ...... f replicon-based DNA vaccines.
@en
type
label
Inhibition of type I allergic ...... f replicon-based DNA vaccines.
@en
prefLabel
Inhibition of type I allergic ...... f replicon-based DNA vaccines.
@en
P2093
P2860
P50
P1433
P1476
Inhibition of type I allergic ...... of replicon-based DNA vaccines
@en
P2093
P2860
P304
P356
10.1111/J.1398-9995.2006.01142.X
P577
2006-07-01T00:00:00Z